Literature DB >> 16425421

Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells.

Wen-Bin Liu1, Xing-Peng Wang, Kai Wu, Ru-Ling Zhang.   

Abstract

AIM: To investigate the effects of AT1 (Type 1 angiotensin II receptor) antagonist (Losartan) on the apoptosis, proliferation and migration of the human pancreatic stellate cells (hPSCs).
METHODS: hPSCs were isolated from pancreatic sample of patients with pancreatic carcinoma using radioimmunoassay (RIA) technique to detect the concentration of AngII in culture media and cell homogenate. Immunocytochemistry (ICC) and in situ hybridization (ISH) methods were utilized to test AT1 expression in hPSCs. Effects of Losartan on hPSCs proliferation, apoptosis and migration were investigated using BrdU incorporation, TUNEL, flow cytometry (FCM), and phase-contrast microscope separately when cells treated with Losartan. Immunofluorescence and Western blot were applied to quantify the expression of type I collagen in hPSCs.
RESULTS: There exists AT1 expression in hPSCs, while no AngII was detected in culture media and cell homogenate. Losartan induces cell apoptosis in a dose- and time-dependent manner (apparently at 10(-5) mol/L), no pro-proliferative effect was observed in the same condition. Corresponding dosage of Losartan can also alleviate the motion capability and type I collagen content of hPSCs compared with AngII treatment and non-treatment control groups.
CONCLUSION: These findings suggest that paracrine not autocrine functions of AngII may have effects on hPSCs, which was mediated by AT1 expressed on cells, while Losartan may exert anti-fibrotic effects by inhibiting hPSCs motion and partly by inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425421      PMCID: PMC4355791          DOI: 10.3748/wjg.v11.i41.6489

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

Authors:  J R Jonsson; A D Clouston; Y Ando; L I Kelemen; M J Horn; M D Adamson; D M Purdie; E E Powell
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.

Authors:  Atsushi Kuno; Tamaki Yamada; Kazuhiko Masuda; Kumiko Ogawa; Mitsue Sogawa; Soichi Nakamura; Takahiro Nakazawa; Hirotaka Ohara; Tomoyuki Nomura; Takashi Joh; Tomoyuki Shirai; Makoto Itoh
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

3.  Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas.

Authors:  W P Chan; M L Fung; R Nobiling; P S Leung
Journal:  Mol Cell Endocrinol       Date:  2000-02-25       Impact factor: 4.102

4.  Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R.

Authors:  Xing-Peng Wang; Ruling Zhang; Kai Wu; Liying Wu; Yuwei Dong
Journal:  Pancreas       Date:  2004-11       Impact factor: 3.327

5.  Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues.

Authors:  Tetsuo Ohta; Kohji Amaya; Shuangqin Yi; Hirohisa Kitagawa; Masato Kayahara; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Gen-Ichi Nishimura; Koichi Shimizu; Koichi Miwa
Journal:  Int J Oncol       Date:  2003-09       Impact factor: 5.650

6.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

Authors:  M J Pollman; T Yamada; M Horiuchi; G H Gibbons
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

7.  Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice.

Authors:  Yoshikuni Nagashio; Hiroshi Asaumi; Shiro Watanabe; Yoko Nomiyama; Masashi Taguchi; Mitsuo Tashiro; Takeshi Sugaya; Makoto Otsuki
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-11       Impact factor: 4.052

8.  Production and effects of endothelin-1 in rat pancreatic stellate cells.

Authors:  Hanne Klonowski-Stumpe; Roland Reinehr; Richard Fischer; Ulrich Warskulat; Reinhard Lüthen; Dieter Häussinger
Journal:  Pancreas       Date:  2003-07       Impact factor: 3.327

9.  Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis.

Authors:  Siu Po Ip; Siu Wai Tsang; Tung Po Wong; Chun Tao Che; Po Sing Leung
Journal:  Pancreas       Date:  2003-04       Impact factor: 3.327

10.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

Authors:  M G Bachem; E Schneider; H Gross; H Weidenbach; R M Schmid; A Menke; M Siech; H Beger; A Grünert; G Adler
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  7 in total

1.  Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.

Authors:  Dov Wengrower; Giuliana Zanninelli; Giovanni Latella; Stefano Necozione; Issa Metanes; Eran Israeli; Joseph Lysy; Mark Pines; Orit Papo; Eran Goldin
Journal:  Can J Gastroenterol       Date:  2012-01       Impact factor: 3.522

2.  Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation.

Authors:  Micheline M de Resende; Andrew S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

3.  Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer.

Authors:  Marcelo Cerullo; Faiz Gani; Sophia Y Chen; Joseph K Canner; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

4.  Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.

Authors:  Min Ae Cho; Soo Young Jeong; Insuk Sohn; Myeong-Seon Kim; Jun Hyeok Kang; E Sun Paik; Yoo-Young Lee; Chel Hun Choi
Journal:  Cancer Res Treat       Date:  2020-01-16       Impact factor: 4.679

5.  Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.

Authors:  Vikash P Chauhan; John D Martin; Hao Liu; Delphine A Lacorre; Saloni R Jain; Sergey V Kozin; Triantafyllos Stylianopoulos; Ahmed S Mousa; Xiaoxing Han; Pichet Adstamongkonkul; Zoran Popović; Peigen Huang; Moungi G Bawendi; Yves Boucher; Rakesh K Jain
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.

Authors:  Xiaoxu Zhao; Jinghua Pan; Wei Li; Wende Yang; Li Qin; Yunlong Pan
Journal:  Int J Nanomedicine       Date:  2018-10-09

Review 7.  Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Andrew Cannon; Christopher Michael Thompson; Rakesh Bhatia; Katharine Anne Armstrong; Joyce Christopher Solheim; Sushil Kumar; Surinder Kumar Batra
Journal:  J Gastroenterol       Date:  2021-07-19       Impact factor: 6.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.